peter l. slavin, m.d., 2015 leadership in academic medicine lecture

47
1 The Future of Academic Medicine Peter L. Slavin, MD President, Massachusetts General Hospital Professor, Health Care Policy, Harvard Medical School August 6, 2015

Upload: uabsom

Post on 19-Aug-2015

37 views

Category:

Health & Medicine


2 download

TRANSCRIPT

Page 1: Peter L. Slavin, M.D., 2015 Leadership in Academic Medicine Lecture

1

The Future of Academic Medicine

Peter L. Slavin, MDPresident, Massachusetts General Hospital

Professor, Health Care Policy, Harvard Medical School

August 6, 2015

Page 2: Peter L. Slavin, M.D., 2015 Leadership in Academic Medicine Lecture

Agenda

Health Care in the United States

Benefits of Academic Medical Centers

MGH at a Glance

How We are Bending the Cost Curve

2

Page 3: Peter L. Slavin, M.D., 2015 Leadership in Academic Medicine Lecture

THE US HEALTH CARE ENVIRONMENT

3

Page 4: Peter L. Slavin, M.D., 2015 Leadership in Academic Medicine Lecture

Health Care Costs are High – and Rising

1960 – $30 billion

1980 – $200 billion

2000 – $1.3 trillion – or 15% of GDP

2013 - $2.9 trillion – or 17.4% of GDP

2020 – estimated $4.6 trillion – 19.8% of GDP

Source: Centers for Medicare and Medicaid Services, 2013

Page 5: Peter L. Slavin, M.D., 2015 Leadership in Academic Medicine Lecture

5

U.S. Health Care Costs In 2013, the United States spent $2.9 trillion, or 17.4

percent of gross domestic product (GDP), on health care – translates to $8,915 per person annually

Projections for health care costs in 2020 are $4.64 trillion, or 19.8 percent of GDP, which would be $13,708 per person

U.S. spends more on health care than any other developed country, but unlike countries that provide universal coverage, 13.4 percent of Americans are uninsured

Vital for hospitals to do what they can to take costs out of the system

Page 6: Peter L. Slavin, M.D., 2015 Leadership in Academic Medicine Lecture

6

Rising Health Care Costs have Squeezed Employers and Employees for Years

Cumulative Increases in National Health Care Premiums, Workers’ Contributions to Premiums, Inflation, and Workers’ Earnings, 1999-2014

SOURCE: Kaiser/HRET Survey of Employer-Sponsored Health Benefits, 1999-2014.

Page 7: Peter L. Slavin, M.D., 2015 Leadership in Academic Medicine Lecture

High Costs – Difficult Choices

7

Politicians must address tough questions about limited resources. How many teachers are you willing to fire in order to have 78-year olds have a procedure which will be invented five years from now that adds four months to their life? That sounds terrible, but infinitely choosing those things will shift you away from education for the young, and towards infinite invention of such [medical] procedures.

Bill GatesFinancial TimesFebruary 22, 2011

Page 8: Peter L. Slavin, M.D., 2015 Leadership in Academic Medicine Lecture

ACADEMIC MEDICAL CENTERS

8

Page 9: Peter L. Slavin, M.D., 2015 Leadership in Academic Medicine Lecture

AMCs have Higher Average Costs

9

3,974 3,984 3,993

2,214 1,389 985

2,360

674 260

8,548

6,047

5,238

0

2,000

4,000

6,000

8,000

10,000

AHC Other Teaching Hospital Type Other Urban Community

Cost Per Case, 1998

Multiple Mission

Wages & Case Mix

Base

Source: Analysis of American Hospital Association data by the Lewin Group, 1998.

Page 10: Peter L. Slavin, M.D., 2015 Leadership in Academic Medicine Lecture

What Makes Up Those Higher Costs?

10

Standby capacity refers to capacity to provide high-technology or intensive services when needed.Source: Analysis of American Hospital Association data by Lewin Group, 1998.

Standby Capac-ity*45%

Research13%

Indirect Medical Education Costs

42%

Distribution of Mission-Related Costs for AHCs, 1998

Page 11: Peter L. Slavin, M.D., 2015 Leadership in Academic Medicine Lecture

Teaching Hospitals, an Economic Engine

11

Source: Conference of Boston Teaching Hospitals

Page 12: Peter L. Slavin, M.D., 2015 Leadership in Academic Medicine Lecture

Academic Medical Centers…

Have higher mission and personnel-related costs

Are research powerhouses

Garner support from a multitude of benefactors

Train future health care leaders

Provide thousands of jobs and drive the economy

Have the potential to transform the health care environment

12

Page 13: Peter L. Slavin, M.D., 2015 Leadership in Academic Medicine Lecture

13

MASSACHUSETTS GENERAL HOSPITAL

Page 14: Peter L. Slavin, M.D., 2015 Leadership in Academic Medicine Lecture

Our Mission

Guided by the needs of our patients and their families, we aim to deliver the very best health care in a safe, compassionate environment; to advance that care through innovative research and education; and to improve the health and well-being of the diverse communities we serve.

Page 15: Peter L. Slavin, M.D., 2015 Leadership in Academic Medicine Lecture

Two Key Affiliations

1811 –

1994 –

15

Page 16: Peter L. Slavin, M.D., 2015 Leadership in Academic Medicine Lecture

Clinical Services

MGH offers care in primary care and virtually every medical and surgical specialty and subspecialty

Multiple specialized intensive care units to care for sickest patients

1 in 6 patients transferred from other hospitals Level-1 trauma center and advanced emergency

preparedness system

16

Page 17: Peter L. Slavin, M.D., 2015 Leadership in Academic Medicine Lecture

Facts and Figures (2014)999 available beds49,334 inpatient admissionsMore than 41,000 surgical cases3,950 births a yearMore than 1.6 million outpatient and emergency

visits At least 300,000 of these visits take place at a

community health center

Page 18: Peter L. Slavin, M.D., 2015 Leadership in Academic Medicine Lecture

18

MGH Research Revenue by Sponsor MGH conducts the largest hospital-based

research program in the United States

Note: Research Activity, excluding Other Science and P&L deductions for capital and reserves. Net P&L revenue is $750M.

Sundry19%

DHHS46%

ARRA0%

Other Federal4%

Foundations7%

Non-Profit16%

Industry8%

State/Local0%

FY2014 Direct + Indirect Research Revenue by Sponsor =$739M

Page 19: Peter L. Slavin, M.D., 2015 Leadership in Academic Medicine Lecture

19

Education at MGH More than 2,200 MGH doctors teach the next generation

of physicians as residents and fellows

The MGH provides Harvard Medical School students with approximately 500 “core clerkship” experiences

The MGH sponsors GME in 17 core specialties and offers 90 subspecialty GME training programs

MGH Institute of Health Professions offers graduate training to more than 900 students in nursing, communication science, physical therapy and imaging

Knight Nursing Center offers wide range of continuing education programs for staff in Patient Care Services

Page 20: Peter L. Slavin, M.D., 2015 Leadership in Academic Medicine Lecture

BENDING THE COST CURVE

20

Page 21: Peter L. Slavin, M.D., 2015 Leadership in Academic Medicine Lecture

Preparing for the Future: MGH/MGPO Strategic Framework

21

Page 22: Peter L. Slavin, M.D., 2015 Leadership in Academic Medicine Lecture

MGH/Partners HealthCare Aggressively Pursuing Ways to Reduce Costs

Leadership opportunity to bend cost curve Efforts to reduce health care spending not going

away – government and private sector being proactive

Our readiness to care for populations of patients

Our Approach: Varied technological interventions Population Health Initiatives

22

Page 23: Peter L. Slavin, M.D., 2015 Leadership in Academic Medicine Lecture

23

Managing Health Care Costs by Managing Populations

Inpatient and Outpatient Encounters

Episodes of Illness

Population Management

23

New models to manage patients and deliver care

Targeted interventions address known issues

Success evaluated over years of work—we strategize and experiment to address issues that face our population and our communities

Page 24: Peter L. Slavin, M.D., 2015 Leadership in Academic Medicine Lecture

CMS Demonstration Project Starting in 2006, targeted sickest 10% of Medicare

beneficiaries, responsible for 70% of Medicare spending Patients had multiple chronic conditions, benefit from ongoing

management Improved care coordination and communication between

patients and care team through care managers Effective deployment of advanced practitioners Outcomes:

Higher satisfaction for patients and providers Lower hospitalization rates Lower ED visit rates Lower mortality rates Lower cost of care

Expanded across Partners and to all Medicare patients covered by Pioneer ACO, and to some commercial patients

24

Page 25: Peter L. Slavin, M.D., 2015 Leadership in Academic Medicine Lecture

Population Health Management

25

Page 26: Peter L. Slavin, M.D., 2015 Leadership in Academic Medicine Lecture

Care of High-Risk Medicare Patients – iCMP

26

Page 27: Peter L. Slavin, M.D., 2015 Leadership in Academic Medicine Lecture

Navigating the Patient Journey

27

*Patient reported outcome measures

Page 28: Peter L. Slavin, M.D., 2015 Leadership in Academic Medicine Lecture

Demonstrating Value for Patient, Caregiver

28

Page 29: Peter L. Slavin, M.D., 2015 Leadership in Academic Medicine Lecture

Navigating the Patient Journey: Progress

29

Page 30: Peter L. Slavin, M.D., 2015 Leadership in Academic Medicine Lecture

eConsults Example: Cardiac CurbsideOnline Consult from PCP to Specialist

30

Page 31: Peter L. Slavin, M.D., 2015 Leadership in Academic Medicine Lecture

31

Technology can Help Reduce Costs

Implementation of Epic for health records and revenue cycle—evolving beyond Meaningful Use.

Decision support tools to drive appropriate use of diagnostic tools and procedures.

Initiatives to reduce administrative burden to keep practitioners working at the top of their licenses.

Patients involved in their care through online portal—develops active, engaged consumers of health care.

Increasing use of Telehealth (virtual visits)—began in Psychiatry and extending into other areas.

Exploring opportunities to leverage big data with EDWs and data visualization tools.

Page 32: Peter L. Slavin, M.D., 2015 Leadership in Academic Medicine Lecture

Community Health Initiative: Substance Use Disorders

Prevalent issue in Massachusetts Complex, downstream effects Typically treated as episodes present in our ED More than 2,000 SUD patients admitted to MGH annually Longer length of stay, higher readmission rate

MGH has developed a multipronged, continuous care solution to address these issues: Multidisciplinary inpatient addiction consult team Community health center support, recovery coaches Connection to other community resources Tailored wellness plans

32

Page 33: Peter L. Slavin, M.D., 2015 Leadership in Academic Medicine Lecture

Addiction

“The question is frequently asked: Why does a man become a drug addict? The answer is that he usually does not intend to. [The drug] wins by default. I tried it as a matter of curiosity… I ended up hooked. You don’t decide to be an addict. One morning you wake up sick and you’re an addict. ”

William S. Burroughs, Junky (1953)

Page 34: Peter L. Slavin, M.D., 2015 Leadership in Academic Medicine Lecture

Natural History of Opioid Use DisorderW

ithdr

awal

Nor

mal

Eup

horia

Chronic useAcute use

Tolerance & Physical Dependence

Slide courtesy of Dan Alford, 2012

Page 35: Peter L. Slavin, M.D., 2015 Leadership in Academic Medicine Lecture

Substance Use Disorder: A national and a local problem

Illicit drug use: 24.6 million users 681,000 heroin users OD quadrupled since 1999

SUD: 21.6 million with SUD 2.5 mil (11%) treated

Boston Metro area: Highest ED visits for drugs Heroin 4 times higher

SAMHSA (2013) NSDUH Series H-48, HHS publication No. (SMA) 14-4863.SAMHSA (2011) NSDUH Series H-41, HHS publications No. (SMA) 11-4658.

Page 36: Peter L. Slavin, M.D., 2015 Leadership in Academic Medicine Lecture

What is Addiction?Primary, chronic brain disease characterized by

compulsive drug use despite harmful consequences

American Society of Addiction Medicine. April 12, 2011. www.asam.orgNIDA. August, 2010. http://www.drugabuse.gov/publications/science-addiction

Diseased Heart

Decreased Heart Metabolism in Coronary Artery Disease

High

Low

Decreased Brain Metabolism in Addiction

Page 37: Peter L. Slavin, M.D., 2015 Leadership in Academic Medicine Lecture

Visualizing Recovery

Volkow et al. J. Neurosci., December 1, 2001, 21(23):9414–9418

Normal

Reduced function

Return to normal

Page 38: Peter L. Slavin, M.D., 2015 Leadership in Academic Medicine Lecture

A Chronic & Treatable Disease

NIDA. Principles of Drug Addiction Treatment. 2012. McLellan et al., JAMA, 284:1689-1695, 2000 .

Page 39: Peter L. Slavin, M.D., 2015 Leadership in Academic Medicine Lecture

39

Comprehensive Approach: From Prevention to Chronic Disease Management

Inpatient(ACT)

OutpatientCommunit

y

Recovery Coaches

Bridge Clinic

Prevention, Education & Evaluation

Page 40: Peter L. Slavin, M.D., 2015 Leadership in Academic Medicine Lecture

Maintaining and Building Referrals Network

40

Page 41: Peter L. Slavin, M.D., 2015 Leadership in Academic Medicine Lecture

Expanding Regional and Global Outreach

41

Page 42: Peter L. Slavin, M.D., 2015 Leadership in Academic Medicine Lecture

MGH Cancer Center: Toward Integrated Cancer Research and Clinical Care

42

Page 43: Peter L. Slavin, M.D., 2015 Leadership in Academic Medicine Lecture

Targeted Therapies: Changing Standard of Care for Common Malignancies

43

Page 44: Peter L. Slavin, M.D., 2015 Leadership in Academic Medicine Lecture

Selecting Targeted Therapies Based on Genetic Abnormalities Within Each Tumor

44

Page 45: Peter L. Slavin, M.D., 2015 Leadership in Academic Medicine Lecture

Termeer Center at MGH

45

Page 46: Peter L. Slavin, M.D., 2015 Leadership in Academic Medicine Lecture

Termeer Center Efforts

46

Page 47: Peter L. Slavin, M.D., 2015 Leadership in Academic Medicine Lecture

The Future of Academic Medicine

Pursue four pronged mission: Care, Research, Education, Community Health

Deliver clinical excellence Advance our knowledge of human biology to improve

prevention, diagnosis, and treatment of human disease Innovate in care delivery to improve care and make it

more affordable

47